⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PLX News
Protalix BioTherapeutics, Inc. Common Stock
Protalix Biotherapeutics and Secarna Pharmaceuticals Enter into Collaboration and Option Agreement
prnewswire.com
PLX
LimeLife Migrates to Ordergroove to Power Scalable, Modern Subscriber Experiences for Global Direct Selling Business
globenewswire.com
ORDR
LRLCF
HLF
PLX
CORRECTION: Pluristyx Launches Organoid COMMONS, Uniting Industry Leaders to Revolutionize Drug Discovery
globenewswire.com
PLX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Protalix BioTherapeutics, Inc. - PLX
accessnewswire.com
PLX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Protalix BioTherapeutics, Inc. - PLX
accessnewswire.com
PLX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Protalix BioTherapeutics, Inc. - PLX
accessnewswire.com
PLX
Protalix BioTherapeutics, Inc. (PLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
accessnewswire.com
PLX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Protalix BioTherapeutics, Inc. - PLX
accessnewswire.com
PLX
Protalix BioTherapeutics to Announce Third Quarter 2025 Financial and Business Results on November 13, 2025
prnewswire.com
PLX
Bronstein, Gewirtz & Grossman, LLC Encourages Protalix BioTherapeutics, Inc. (PLX) Shareholders to Inquire about Securities Investigation
accessnewswire.com
PLX